What Boston Pharma does

Boston Pharma (legal name: Công Ty Cổ Phần Dược Phẩm Boston Việt Nam) is a privately held Vietnamese generic pharmaceutical manufacturer founded in November 2007 and headquartered in Ho Chi Minh City, with its EU GMP-certified production facility in the Vietnam-Singapore Industrial Park, Binh Duong. The company manufactures 300+ pharmaceutical products spanning five therapeutic groups — analgesics/anti-inflammatories, antibiotics, antivirals, gastrointestinal, endocrine, and respiratory — alongside a portfolio of health supplements. Annual production capacity exceeds 4 billion units, supported by approximately 1,400 employees operating across headquarters, five domestic branch offices, and a Lisbon representative office.

The company's core technology stack centers on EU GMP-certified manufacturing using US production technology and EU/USP/JP/BP standard ingredients, with proprietary QR-code traceability on every product and a Boston 360 anti-counterfeit image-comparison application, plus a Voicebot AI customer service hotline (1900 1910). The Boston Sale mobile app enables pharmacy partners to place orders, track shipments in real time, and manage promotional programs. Boston Pharma is differentiated by EU GMP certification from the Portuguese Pharmaceutical Authority (effective September 2022), ISO 9001:2015 quality management certification (2025), and a direct factory-to-pharmacy distribution model that bypasses intermediaries to mitigate counterfeit risk.

Commercially, Boston Pharma sells prescription and OTC medicines plus dietary supplements to pharmacies, hospitals, and end consumers across Vietnam via a nationwide trình dược viên field sales force. In April 2026, the company signed a strategic partnership with Pharmacity to co-develop an exclusive product portfolio, signaling a shift toward anchor enterprise accounts alongside its long-tail pharmacy distribution. Pricing is not publicly disclosed; revenue is generated through unit sales of physical products rather than licensing or subscription models.

Name

Boston Pharma

Legal name

Công Ty Cổ Phần Dược Phẩm Boston Việt Nam

Website

https://bostonpharma.com.vn

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Boston Pharma is a Vietnamese generic pharmaceutical manufacturer producing 300+ EU GMP-certified medicines and health supplements at its Binh Duong facility, distributing directly to pharmacies and hospitals nationwide through a 1,400-person field sales force and proprietary digital platforms.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Small-Molecule Generics (Branded/Unbranded) (HLAIABAA)

akta.pro secondary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

Keywords

• Generic pharmaceuticals
• Health supplements
• EU GMP manufacturing
• Anti-counterfeit traceability
• Pharmacy distribution

Headquarters

HQ city

Ho Chi Minh City

HQ country

Vietnam

HQ region

Asia

Offices7 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Products: Manufacturing and direct sale of prescription and OTC medicines across therapeutic categories including analgesics, antibiotics, antivirals, gastrointestinal, endocrine, and respiratory products.
2. Health Supplements (Thực phẩm bảo vệ sức khỏe): Manufacturing and sale of dietary supplements and functional health products including nutritional supplements, digestive support, musculoskeletal support, cough/lung tonics, and liver/gallbladder tonics.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels8 records

Core offering

Boston Pharma manufactures and directly sells EU GMP-certified generic pharmaceutical medicines and over-the-counter health supplements to pharmacies, hospitals, and consumers in Vietnam. The portfolio spans analgesics/anti-inflammatories, antibiotics, antivirals, gastrointestinal, endocrine, and respiratory therapeutic groups, alongside nutritional and functional supplements, produced at an EU GMP-certified facility with proprietary QR code anti-counterfeit traceability on every product.

Product overview

Boston Pharma is a Vietnamese pharmaceutical company with a diverse portfolio of prescription medicines and over-the-counter health supplements. Their prescription medicines include anti-inflammatory/analgesic products (Paralmax line with variants: Extra, 500, Pain, Cold-Flu, 650, and powder forms), antibiotics (Cefalex 500), antivirals (MOLRAVIR 400), and gastrointestinal medications (Omeraz 20). The Paralmax product line is their flagship analgesic/anti-inflammatory brand with multiple dosage forms including tablets, capsules, powder sachets, and effervescent tablets. Their OTC health supplements include Tocomax Plus, Bosmaton Plus, Bozypaine, Ivy Boston, Bostine Gold, Creatin Boston, Hepotec, and Vitar-Junior. The company also operates digital platforms including the Boston Sale app for pharmacy ordering and a QR code traceability system for product authentication, along with Voicebot AI customer service.

Differentiator

Problem solved

Functional benefit

Brands

• Boston Sale: Mobile application for pharmacy partners to place orders and track shipments
• Boston 360
• Voicebot AI

Products and services

• Paralmax Line (Analgesics/Anti-inflammatory) Flagship brand of anti-inflammatory, analgesic, and antipyretic medicines for pain and fever relief, sold to pharmacies and hospitals for prescription and OTC dispensing to consumers.
• Cefalex 500 Antibiotic medication containing Cephalexin supplied in boxes of 200 capsules for prescription dispensing by pharmacies and hospitals.
• MOLRAVIR 400 Antiviral medication for the treatment of viral infections, supplied to pharmacies and hospitals for prescription dispensing.
• BOSTOGEL Topical anti-inflammatory and analgesic gel medication supplied to pharmacies for pain and inflammation relief.
• Bostacet Pharmaceutical product in the Boston Pharma medication portfolio distributed to pharmacies and hospitals.
• Omeraz 20 Gastrointestinal medication for acid-related conditions, supplied in bottle format to pharmacies and hospitals.
• METHYLBOSTON 4 Medication available in 200 or 500 tablet bottles for various therapeutic applications, supplied to pharmacies and hospitals.
• Conoges 100 (EU) EU-standard pharmaceutical product presented in boxes of 3 blisters x 10 hard capsules, supplied to pharmacies and hospitals.
• Health Supplements (OTC Line) Over-the-counter health supplements including nutritional supplements, digestive support, musculoskeletal support, cough/lung tonics, liver/gallbladder tonics, and children's health (Vitar-Junior), sold through pharmacies directly to consumers without prescription.

Quantifiable outcome

• EU GMP-certified manufacturing since September 2022, enabling potential substitution for imported originator and generic drugs at lower cost with equivalent therapeutic effect.

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• PharmacitycoreChannel Partner/ Reseller/ Distributor · 27 April 2026Boston Pharma signed a strategic cooperation agreement with Pharmacity in April 2026 to develop an exclusive product portfolio. Pharmacity is a major pharmacy chain in Vietnam. The partnership involves direct supply and exclusive product development between Boston Pharma and Pharmacity stores nationwide.
• Cơ quan Quản lý Dược phẩm Bồ Đào Nha (Portuguese Pharmaceutical Authority)coreOthersThe Portuguese Pharmaceutical Authority conducted on-site assessments of Boston Pharma's Binh Duong manufacturing facility and awarded EU GMP certification from September 2022, confirming compliance with European Good Manufacturing Practice standards.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Abbott Vietnam: Abbott operates in Vietnam across pharmaceuticals, nutrition, and consumer health (e.g., analgesic/OTC brands), providing broad competition to Boston Pharma in OTC analgesics and health supplements through its multinational brand portfolio.
• Sanofi Vietnam: Sanofi is a global pharmaceutical incumbent with a significant consumer healthcare (OTC analgesics, cough/cold) presence in Vietnam that competes with Boston Pharma's Paralmax line. It is a broader incumbent rather than a pure domestic peer.

Direct peers

• OPC Pharmaceutical: OPC is a Vietnamese generic pharmaceutical manufacturer producing tablets, capsules, syrups, and OTC health products distributed nationwide through pharmacies. It is comparable to Boston Pharma in domestic generics + health supplement portfolio and pharmacy-channel focus.
• Imexpharm: Imexpharm is a Vietnamese-listed generic pharmaceutical company producing antibiotics, cardiovascular, and metabolic drugs through WHO-GMP facilities. It is a close competitor in the same Vietnamese generics therapeutic categories as Boston Pharma.
• DHG Pharmaceutical (Hau Giang Pharma): DHG Pharma is the largest domestic generic pharmaceutical manufacturer in Vietnam, producing tablets, capsules, syrups, and OTC health supplements. It is the most direct head-to-head competitor for Boston Pharma across OTC, antibiotics, analgesics, and pharmacy-channel generic supply in Vietnam.
• Traphaco: Traphaco is a leading Vietnamese pharmaceutical company combining modern medicines and traditional/Herbal medicine, with a broad distribution network to pharmacies nationwide. It competes with Boston Pharma across both prescription generics and OTC/health supplement categories.
• Pymepharco: Pymepharco is a Vietnamese-listed generic pharmaceutical manufacturer with EU-GMP-certified facilities producing antibiotics, anti-infectives, and cardiovascular products. It directly competes with Boston Pharma in EU GMP-certified generics and hospital-channel supply in Vietnam.
• Domesco Medical Import-Export: Domesco is a Vietnamese pharmaceutical manufacturer producing generic medicines across cardiovascular, anti-infective, and OTC categories, supplying both domestic pharmacies and export markets. It competes with Boston Pharma in Vietnamese pharmacy-channel generics.
• Mekophar Chemical & Pharmaceutical: Mekophar is a Vietnamese manufacturer of generic pharmaceuticals and APIs (including some cephalosporin antibiotics), with WHO-GMP and EU-GMP-certified facilities. It overlaps with Boston Pharma's antibiotic and small-molecule generic portfolio.

Others

• Pharmacity: Pharmacity is Vietnam's largest retail pharmacy chain and Boston Pharma's strategic channel partner since April 2026. While not a competitor, Pharmacity is a key ecosystem participant whose exclusive-product partnership with Boston Pharma directly shapes Boston Pharma's volume trajectory.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/c/BostonPharma
• Facebookfacebook.com/BostonVN
• LinkedInlinkedin.com/company/boston-pharma-vietnam
• Instagraminstagram.com/bostonpharmavietnam

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Boston Pharma